✦ LIBER ✦

Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation

✍ Scribed by Hidalgo-Vega, Álvaro; Askari, Elham; Vidal, Rosa; Aranda-Reneo, Isaac; Gonzalez-Dominguez, Almudena; Ivanova, Alexandra; Ene, Gabriela; Llamas, Pilar

Book ID: 121556063
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 499 KB
Volume: 14
Category: Article
ISSN: 1472-6963
DOI: 10.1186/1472-6963-14-46

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV63 Direct Health Care Costs of Oral A

PCV63 Direct Health Care Costs of Oral Anticoagulant Treatment in Patients with Non Valvular Atrial Fibrillation

✍ E. Askari; A. Hidalgo; R. Villoro; R. Vidal; C. Miranda; G.S. Ene; A. Ivanova; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCV3 COMPARISON OF MORTALITY, HEALTH CAR

PCV3 COMPARISON OF MORTALITY, HEALTH CARE UTILITY AND COST OF PATIENTS WITH WARFARIN TREATMENT FOR NON-VALVULAR ATRIAL FIBRILLATION VERSUS PATIENTS WITH OTHER TREATMENT

✍ L Wang; O Baser 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Direct anticoagulant drugs to overcome l

Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients

✍ Di Minno, Matteo Nicola Dario; Russolillo, Anna; Di Minno, Alessandro; Camera, M 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 318 KB

PCV35 COMPARISON OF MAJOR BLEEDING RELAT

PCV35 COMPARISON OF MAJOR BLEEDING RELATED MORTALITY, HEALTH CARE UTILIZATION AND COSTS OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

✍ O. Baser; J. Du; L. Xie; E. Baser 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Self-management of Vitamin K Antagonists

Self-management of Vitamin K Antagonists Is More Cost-effective Than Dabigatran for Stroke Prevention in Non-valvular Atrial Fibrillation in Spain

✍ Souto, Juan C.; Ruyra, Xavier; Bayes-Genis, Antoni 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Comparison of cost-effectiveness of anti

Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countries

✍ Krejczy, Martin; Harenberg, Job; Marx, Svetlana; Obermann, Konrad; Frölich, Lutz 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 461 KB